MDGL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 21.50%

Insider Buying (Last 12 Months): $61,921,142.32

Insider Selling (Last 12 Months): $182,355,449.07

Madrigal Pharmaceuticals Insider Trading History Chart

Madrigal Pharmaceuticals Share Price & Price History

^$502.47

▼ -16.19 (-3.12%)

As of 05/5/2026 04:00 PM ET

Days: 30 | 90 | 365

Madrigal Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/6/2026	Carole Huntsman	Insider	Sell	419	$431.94	$180,982.86	12,692
3/6/2026	Mardi Dier	CFO	Sell	1,982	$430.87	$853,984.34	12,490
3/6/2026	Rebecca Taub	Director	Sell	491	$431.94	$212,082.54	452,213
3/6/2026	Shannon T. Kelley	General Counsel	Sell	360	$431.94	$155,498.40	12,138
3/6/2026	William John Sibold	CEO	Sell	1,663	$431.94	$718,316.22	161,829
3/2/2026	Mardi Dier	CFO	Sell	1,183	$427.21	$505,389.43	9,257
1/26/2026	Carole Huntsman	Insider	Sell	910	$493.78	$449,339.80	9,122
1/26/2026	Rebecca Taub	Director	Sell	647	$492.42	$318,595.74	452,704
1/26/2026	William John Sibold	CEO	Sell	1,577	$492.42	$776,546.34	148,497
1/20/2026	Rebecca Taub	Director	Sell	2,238	$490.77	$1,098,343.26	453,351
1/20/2026	Shannon T. Kelley	General Counsel	Sell	692	$497.36	$344,173.12	8,481
1/9/2026	Paul A. Friedman	Director	Sell	280	$551.24	$154,347.20	187,164
1/9/2026	Paul A. Friedman	Director	Sell	24,520	$522.39	$12,809,002.80	187,164
1/9/2026	Rebecca Taub	Director	Sell	240	$550.33	$132,079.20	455,589
1/9/2026	Rebecca Taub	Director	Sell	18,410	$522.40	$9,617,384.00	455,589
12/10/2025	Paul A. Friedman	Director	Sell	24,800	$552.18	$13,694,064.00	187,164
12/10/2025	Rebecca Taub	Director	Sell	18,650	$552.15	$10,297,597.50	461,044
12/4/2025	William John Sibold	CEO	Sell	2,400	$575.34	$1,380,816.00	150,074
12/2/2025	Mardi Dier	CFO	Sell	4,173	$578.34	$2,413,412.82	10,440
11/21/2025	Carole Huntsman	Insider	Sell	1,958	$553.11	$1,082,989.38	10,032
11/13/2025	Richard S. Levy	Director	Sell	8,500	$520.96	$4,428,160.00	21,197
11/5/2025	Kenneth Bate	Director	Sell	16,575	$484.30	$8,027,272.50	2,627
9/9/2025	William John Sibold	CEO	Sell	7,279	$445.63	$3,243,740.77	102,474
8/21/2025	William John Sibold	CEO	Sell	7,616	$400.18	$3,047,770.88	109,753
8/20/2025	Bros. Advisors Lp Baker	Director	Buy	59,901	$385.16	$23,071,469.16	1,947,968
8/18/2025	Bros. Advisors Lp Baker	Director	Buy	68,618	$364.04	$24,979,696.72	1,859,091
8/18/2025	Bros. Advisors Lp Baker	Director	Buy	37,164	$373.21	$13,869,976.44	1,893,120
8/18/2025	Shannon T. Kelley	General Counsel	Sell	1,304	$367.81	$479,624.24	9,173
8/15/2025	Kenneth Bate	Director	Sell	10,000	$365.20	$3,652,000.00	2,627
8/13/2025	Paul A. Friedman	Director	Sell	129,172	$370.24	$47,824,641.28	187,164
8/12/2025	Paul A. Friedman	Director	Sell	43,605	$355.68	$15,509,426.40	187,164
8/12/2025	Rebecca Taub	Director	Sell	43,263	$355.69	$15,388,216.47	461,044
8/11/2025	Paul A. Friedman	Director	Sell	3,203	$350.27	$1,121,914.81	187,164
8/11/2025	Rebecca Taub	Director	Sell	3,200	$350.24	$1,120,768.00	461,044
7/18/2025	Paul A. Friedman	Director	Sell	1,400	$350.03	$490,042.00	187,164
7/18/2025	Rebecca Taub	Director	Sell	1,000	$350.00	$350,000.00	461,044
7/17/2025	Paul A. Friedman	Director	Sell	2,700	$350.48	$946,296.00	187,164
7/17/2025	Rebecca Taub	Director	Sell	2,657	$350.41	$931,039.37	461,044
7/16/2025	Paul A. Friedman	Director	Sell	26,176	$353.47	$9,252,430.72	187,164
7/16/2025	Rebecca Taub	Director	Sell	26,444	$353.47	$9,347,160.68	461,044
3/5/2025	Robert E. Waltermire	VP	Sell	14,113	$341.32	$4,817,049.16	3,728
2/28/2025	Robert E. Waltermire	VP	Sell	1,227	$341.07	$418,492.89	3,728
2/27/2025	James M. Daly	Director	Sell	15,470	$347.45	$5,375,051.50	1,912
1/24/2025	Carole Huntsman	Insider	Sell	347	$335.24	$116,328.28	10,438
1/24/2025	Rebecca Taub	CMO	Sell	648	$335.24	$217,235.52	456,662
1/24/2025	Robert E. Waltermire	VP	Sell	103	$335.24	$34,529.72	4,955
1/24/2025	William John Sibold	CEO	Sell	1,584	$335.24	$531,020.16	54,303
1/17/2025	Rebecca Taub	CMO	Sell	1,689	$273.41	$461,789.49	457,310
1/17/2025	Robert E. Waltermire	VP	Sell	442	$273.41	$120,847.22	5,058
1/17/2025	Shannon T. Kelley	General Counsel	Sell	277	$273.41	$75,734.57	7,705
12/3/2024	Fred B. Craves	Director	Sell	3,600	$315.31	$1,135,116.00	11,000
11/25/2024	Fred B. Craves	Director	Sell	3,400	$350.30	$1,191,020.00	14,600
11/1/2024	Richard S. Levy	Director	Sell	5,000	$300.94	$1,504,700.00	11,012
9/9/2024	William John Sibold	CEO	Sell	6,363	$243.83	$1,551,490.29	55,887
6/14/2024	Robert E. Waltermire	VP	Sell	1,900	$280.00	$532,000.00	5,500
6/12/2024	Robert E. Waltermire	VP	Sell	2,000	$285.00	$570,000.00	5,500
5/21/2024	Robert E. Waltermire	VP	Sell	1,036	$231.34	$239,668.24	5,500
5/14/2024	Fred B. Craves	Director	Sell	22,489	$212.88	$4,787,458.32	413,362
4/8/2024	Paul A. Friedman	Director	Sell	26,270	$246.19	$6,467,411.30	185,735
4/8/2024	Rebecca Taub	CMO	Sell	2,676	$245.99	$658,269.24	458,999
4/5/2024	Rebecca Taub	CMO	Sell	27,506	$243.36	$6,693,860.16	458,999
4/4/2024	Paul A. Friedman	Director	Sell	18,710	$242.96	$4,545,781.60	185,735
4/3/2024	Rebecca Taub	CMO	Sell	27,845	$245.14	$6,825,923.30	458,999
4/1/2024	James M. Daly	Director	Sell	32,489	$102.77	$3,338,894.53	1,198
4/1/2024	Richard S. Levy	Director	Sell	11,000	$257.48	$2,832,280.00	10,298
12/13/2023	Bros. Advisors Lp Baker	Director	Buy	81,159	$219.39	$17,805,473.01	1,774,294
12/13/2023	Robert E. Waltermire	VP	Sell	2,500	$225.40	$563,500.00	5,667
12/4/2023	Brian Joseph Lynch	SVP	Sell	1,800	$218.87	$393,966.00	15,001
11/29/2023	Brian Joseph Lynch	SVP	Sell	4,000	$199.19	$796,760.00	15,001
11/21/2023	Bros. Advisors Lp Baker	Director	Buy	64,350	$188.47	$12,128,044.50	1,667,104
11/17/2023	Bros. Advisors Lp Baker	Director	Buy	46,370	$174.70	$8,100,839.00	1,588,541
11/14/2023	Bros. Advisors Lp Baker	Director	Buy	34,188	$156.42	$5,347,686.96	1,531,757

SEC Filings (Institutional Ownership Changes) for Madrigal Pharmaceuticals (NASDAQ:MDGL)

98.50% of Madrigal Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Madrigal Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/5/2026	D.A. Davidson & CO.	1,823	$0.95M	0.0%	-14.4%	0.008%
5/5/2026	Bank of New York Mellon Corp	135,908	$71.14M	0.0%	-0.7%	0.590%
5/5/2026	Illinois Municipal Retirement Fund	3,872	$2.03M	0.0%	+103.5%	0.017%
5/5/2026	NFSG Corp	3,478	$1.82M	0.3%	-2.0%	0.015%
5/5/2026	Sanctuary Advisors LLC	1,200	$0.63M	0.0%	-12.5%	0.005%
5/4/2026	Calamos Advisors LLC	3,490	$1.83M	0.0%	-46.8%	0.015%
5/4/2026	Emerald Mutual Fund Advisers Trust	16,500	$8.64M	0.4%	-34.0%	0.072%
5/4/2026	Emerald Advisers LLC	37,654	$19.71M	0.6%	-3.2%	0.163%
5/4/2026	Principal Financial Group Inc.	1,239	$0.65M	0.0%	-82.9%	0.005%
5/4/2026	Chicago Partners Investment Group LLC	777	$0.41M	0.0%	-19.1%	0.003%
5/4/2026	J. Safra Sarasin Holding AG	2,323	$1.22M	0.0%	+50.3%	0.010%
5/1/2026	Fifth Third Bancorp	832	$0.44M	0.0%	N/A	0.004%
5/1/2026	Candriam S.C.A.	84,948	$44.47M	0.2%	+32.9%	0.369%
4/30/2026	Kestra Advisory Services LLC	1,362	$0.71M	0.0%	-13.8%	0.006%
4/30/2026	Seelaus Asset Management LLC	422	$0.22M	0.2%	N/A	0.002%
4/30/2026	Greenwood Capital Associates LLC	682	$0.36M	0.0%	N/A	0.003%
4/28/2026	Abel Hall LLC	1,271	$0.67M	0.1%	+79.0%	0.006%
4/27/2026	Elevation Point Wealth Partners LLC	419	$0.22M	0.0%	-49.2%	0.002%
4/23/2026	AMI Asset Management Corp	2,613	$1.37M	0.1%	-5.1%	0.011%
4/22/2026	Pictet Asset Management Holding SA	187,240	$97.91M	0.1%	+2.9%	0.816%
4/22/2026	Sterling Capital Management LLC	213	$0.11M	0.0%	+74.6%	0.001%
4/20/2026	Banque Cantonale Vaudoise	862	$0.45M	0.0%	N/A	0.004%
4/20/2026	Assenagon Asset Management S.A.	16,033	$8.39M	0.0%	+197.5%	0.070%
4/16/2026	SG Americas Securities LLC	2,711	$1.42M	0.0%	-57.5%	0.012%
3/20/2026	Hsbc Holdings PLC	1,100	$0.65M	0.0%	N/A	0.005%
3/17/2026	Rockefeller Capital Management L.P.	19,661	$11.45M	0.0%	+6.6%	0.086%
2/27/2026	Groupama Asset Managment	30,620	$17.83M	0.3%	+11.6%	0.133%
2/26/2026	Seven Fleet Capital Management LP	1,860	$1.08M	0.8%	N/A	0.008%
2/19/2026	Invesco Ltd.	365,314	$212.74M	0.0%	+21.9%	1.609%
2/18/2026	EP Wealth Advisors LLC	609	$0.36M	0.0%	N/A	0.003%
2/18/2026	XTX Topco Ltd	2,819	$1.64M	0.0%	N/A	0.012%
2/18/2026	Virtus Investment Advisers LLC	1,194	$0.70M	0.2%	-20.1%	0.005%
2/18/2026	Wellington Management Group LLP	461,402	$268.69M	0.1%	+14.1%	2.032%
2/18/2026	SummitTX Capital L.P.	433	$0.25M	0.0%	N/A	0.002%
2/18/2026	Sphera Funds Management LTD.	3,300	$1.92M	0.4%	N/A	0.015%
2/18/2026	Millennium Management LLC	6,978	$4.06M	0.0%	+288.1%	0.031%
2/18/2026	Man Group plc	14,764	$8.60M	0.0%	-30.8%	0.065%
2/18/2026	Inspire Investing LLC	2,256	$1.31M	0.1%	N/A	0.010%
2/18/2026	Janus Henderson Group PLC	1,584,843	$918.20M	0.4%	-14.0%	6.978%
2/18/2026	Engineers Gate Manager LP	8,708	$5.07M	0.1%	+196.8%	0.038%
2/18/2026	Cinctive Capital Management LP	3,687	$2.15M	0.1%	+2.2%	0.016%
2/18/2026	Bamco Inc. NY	2,500	$1.46M	0.0%	-3.8%	0.011%
2/18/2026	Armistice Capital LLC	265,705	$154.73M	1.8%	+6.3%	1.170%
2/17/2026	Guggenheim Capital LLC	2,161	$1.26M	0.0%	+33.0%	0.010%
2/17/2026	Paulson & CO. Inc.	1,707,522	$994.36M	30.5%	-10.5%	7.519%
2/17/2026	ADAR1 Capital Management LLC	895	$0.52M	0.0%	-81.7%	0.004%
2/17/2026	AQR Capital Management LLC	10,006	$5.83M	0.0%	+51.9%	0.044%
2/17/2026	Abel Hall LLC	710	$0.41M	0.1%	+20.3%	0.003%
2/17/2026	EFG International AG	10,373	$6.05M	0.1%	N/A	0.046%
2/17/2026	Cetera Investment Advisers	3,941	$2.30M	0.0%	+5.8%	0.017%
2/17/2026	MPM Bioimpact LLC	96,780	$56.36M	6.4%	-3.6%	0.426%
2/17/2026	Jain Global LLC	52,721	$30.70M	0.1%	N/A	0.232%
2/17/2026	First Light Asset Management LLC	66,831	$38.92M	3.0%	+479.2%	0.294%
2/17/2026	ArrowMark Colorado Holdings LLC	82,624	$48.12M	1.1%	-33.0%	0.364%
2/17/2026	Trexquant Investment LP	7,784	$4.53M	0.0%	N/A	0.034%
2/17/2026	Amundi	437	$0.25M	0.0%	N/A	0.002%
2/17/2026	Jump Financial LLC	19,221	$11.19M	0.1%	-8.3%	0.085%
2/17/2026	Price T Rowe Associates Inc. MD	313,659	$182.66M	0.0%	-11.0%	1.381%
2/17/2026	Rock Springs Capital Management LP	139,618	$81.31M	4.2%	+1.4%	0.615%
2/17/2026	Osaic Holdings Inc.	3,050	$1.78M	0.0%	+280.3%	0.013%
2/17/2026	Advisory Services Network LLC	658	$0.38M	0.0%	N/A	0.003%
2/17/2026	Adage Capital Partners GP L.L.C.	23,226	$13.53M	0.0%	-73.8%	0.102%
2/17/2026	California State Teachers Retirement System	14,008	$8.16M	0.0%	+0.8%	0.062%
2/17/2026	Russell Investments Group Ltd.	48,159	$28.05M	0.0%	+7.3%	0.212%
2/17/2026	Kemnay Advisory Services Inc.	67	$39K	0.0%	N/A	0.000%
2/17/2026	State of Wisconsin Investment Board	9,276	$5.40M	0.0%	-14.7%	0.041%
2/17/2026	Captrust Financial Advisors	1,131	$0.66M	0.0%	+99.8%	0.005%
2/17/2026	Artisan Partners Limited Partnership	198,693	$115.71M	0.2%	-3.7%	0.875%
2/17/2026	&PARTNERS	509	$0.30M	0.0%	N/A	0.002%
2/17/2026	Avoro Capital Advisors LLC	1,807,500	$1.05B	10.1%	-1.4%	7.879%
2/17/2026	Royal Bank of Canada	10,223	$5.95M	0.0%	-49.3%	0.045%
2/17/2026	Graham Capital Management L.P.	1,062	$0.62M	0.0%	N/A	0.005%
2/17/2026	Polar Capital Holdings Plc	270,151	$157.32M	0.6%	+1.9%	1.190%
2/17/2026	Cynosure Group LLC	1,025	$0.60M	0.0%	N/A	0.005%
2/17/2026	Alkeon Capital Management LLC	240,000	$139.76M	0.2%	+100.0%	1.057%
2/16/2026	Vanguard Personalized Indexing Management LLC	1,249	$0.73M	0.0%	+14.7%	0.005%
2/16/2026	Verition Fund Management LLC	8,893	$5.18M	0.0%	+58.0%	0.039%
2/16/2026	MML Investors Services LLC	1,668	$0.97M	0.0%	+20.0%	0.007%
2/16/2026	Mariner LLC	2,426	$1.41M	0.0%	+33.2%	0.011%
2/16/2026	Fieldview Capital Management LLC	5,196	$3.03M	0.5%	+11.6%	0.023%
2/16/2026	Landscape Capital Management L.L.C.	1,088	$0.63M	0.0%	+7.7%	0.005%
2/16/2026	Destination Wealth Management	350	$0.20M	0.0%	N/A	0.002%
2/16/2026	Entropy Technologies LP	6,942	$4.04M	0.2%	+87.5%	0.031%
2/16/2026	Barclays PLC	38,720	$22.55M	0.0%	-22.4%	0.170%
2/16/2026	Aigen Investment Management LP	2,652	$1.54M	0.4%	+353.3%	0.012%
2/13/2026	FORA Capital LLC	1,997	$1.16M	0.1%	-20.2%	0.009%
2/13/2026	Marshall Wace LLP	39,578	$23.05M	0.0%	+5,554.0%	0.174%
2/13/2026	The Manufacturers Life Insurance Company	16,052	$9.36M	0.0%	-7.4%	0.071%
2/13/2026	Segall Bryant & Hamill LLC	33,520	$19.52M	0.3%	+49.0%	0.148%
2/13/2026	Affinity Asset Advisors LLC	31,131	$18.13M	1.0%	-72.9%	0.137%
2/13/2026	Bridgewater Associates LP	19,218	$11.19M	0.0%	-30.8%	0.085%
2/13/2026	Stifel Financial Corp	2,327	$1.36M	0.0%	-10.8%	0.010%
2/13/2026	Quarry LP	55	$32K	0.0%	-36.0%	0.000%
2/13/2026	Virtus Advisers LLC	360	$0.21M	0.1%	N/A	0.002%
2/13/2026	Smartleaf Asset Management LLC	187	$0.11M	0.0%	+50.8%	0.001%
2/13/2026	Bridgefront Capital LLC	393	$0.23M	0.1%	-45.1%	0.002%
2/13/2026	Morgan Stanley	150,462	$87.62M	0.0%	-39.7%	0.663%
2/13/2026	Schroder Investment Management Group	29,051	$16.96M	0.0%	+74.9%	0.128%
2/13/2026	Public Sector Pension Investment Board	32,871	$19.14M	0.1%	N/A	0.145%
2/13/2026	Rafferty Asset Management LLC	10,530	$6.13M	0.0%	-43.7%	0.046%

Data available starting January 2016

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.

Today's Range

Now: $502.47

$497.23

$522.01

50 Day Range

MA: $484.48

$425.85

$546.89

52 Week Range

Now: $502.47

$265.00

$615.00

Volume

331,046 shs

Average Volume

256,566 shs

Market Capitalization

$11.58 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Madrigal Pharmaceuticals?: Madrigal Pharmaceuticals' top insider investors include:
Bruce Kovner (Director)
Safi Bahcall (CEO)
Bros Advisors Lp Baker (Director)
Rebecca Taub (Director)
Rebecca Taub (CMO)
Fred B Craves (Director)
Keith R Gollust (Director)
Bay City Capital Llc (Major Shareholder)
Paul A Friedman (Director)
William John Sibold (CEO)
Learn More about top insider investors at Madrigal Pharmaceuticals.
Who are the major institutional investors of Madrigal Pharmaceuticals?: Madrigal Pharmaceuticals' top institutional shareholders include:
Pictet Asset Management Holding SA — 0.82%
Candriam S.C.A. — 0.37%
Emerald Advisers LLC — 0.16%
Emerald Mutual Fund Advisers Trust — 0.07%
Assenagon Asset Management S.A. — 0.07%
Calamos Advisors LLC — 0.02%
Learn More about top institutional investors of Madrigal Pharmaceuticals stock.
Which major investors are selling Madrigal Pharmaceuticals stock?: During the last quarter, MDGL stock was sold by these institutional investors:
Emerald Mutual Fund Advisers Trust
Principal Financial Group Inc.
SG Americas Securities LLC
Calamos Advisors LLC
Emerald Advisers LLC
Elevation Point Wealth Partners LLC
Kestra Advisory Services LLC
Chicago Partners Investment Group LLC
Within the previous year, company insiders that have sold Madrigal Pharmaceuticals company stock include:
Rebecca Taub (Director)
Paul A Friedman (Director)
William John Sibold (CEO)
Richard S Levy (Director)
Carole Huntsman (Insider)
Mardi Dier (CFO)
Shannon T Kelley (General Counsel)
Kenneth Bate (Director)
Learn More investors selling Madrigal Pharmaceuticals stock.
Which major investors are buying Madrigal Pharmaceuticals stock?: Within the last quarter, MDGL stock was purchased by institutional investors including:
Candriam S.C.A.
Assenagon Asset Management S.A.
Pictet Asset Management Holding SA
Banque Cantonale Vaudoise
Fifth Third Bancorp
J. Safra Sarasin Holding AG
Greenwood Capital Associates LLC
Abel Hall LLC